Facing a New TrialSun & Moon · 2017Lycanroc-GX
TCGPlayer market
$4.95
- PSA 10
- $20.69
Finish
Market prices
Ungraded prices from each marketplace we track, with sales activity where available.
TCGPlayer Market USD
$4.95
TCGPlayer Market
USD
—
eBay Average USD
$5.03
eBay Average
USD
—
eBay Sold USD
$3.97
eBay Sold
USD
—
Graded prices
Average sold price by grading company and grade.
- Grade 10
- $20.691 sold
| Grader | 10 |
|---|---|
| PSA | $20.691 sold |
Population report
How many copies each grading company has graded, and at which grade.
CGC graded
29
Gem rate
Price by condition
Ungraded market price for each printing, from Near Mint down to Damaged.
Holofoil
NM
Near Mint
$5.00
LP
Lightly Played
–
MP
Moderately Played
–
HP
Heavily Played
–
DM
Damaged
–
Got Lycanroc-GX? Scan the rest of your binder.
Point your camera at a card and PokiFrame identifies it and pulls live prices in about a second — free for iPhone and Android.
About Lycanroc-GX
Lycanroc-GX is a Japanese Pokémon card (#034) from Facing a New Trial, part of the Sun & Moon series, released in 2017.
An ungraded copy currently sells for about $4.95. A PSA 10 (Gem Mint) averages $20.69 — about 4.2× the raw price.
PokiFrame tracks Lycanroc-GX across TCGPlayer, Cardmarket and eBay sales so you can check its value before you buy, sell or trade.
Lycanroc-GX — common questions
- How much is Lycanroc-GX worth?
- Lycanroc-GX from Facing a New Trial has a market price of $4.95 for an ungraded copy, based on current TCGPlayer and eBay sales data. Condition, print variant and grading all move that number.
- What is a PSA 10 Lycanroc-GX worth?
- Recent PSA 10 (Gem Mint) sales of Lycanroc-GX averaged $20.69, about 4.2× the ungraded price.
More from Facing a New Trial
All Facing a New Trial cards
Bellsprout
Facing a New Trial
Market
$4.71

Weepinbell
Facing a New Trial
Market
$4.02

Victreebel
Facing a New Trial
Market
$10.10

Ledyba
Facing a New Trial
Market
$0.89

Ledian
Facing a New Trial
Market
$0.97

Tapu Bulu
Facing a New Trial
Market
$1.01

Tapu Bulu-GX
Facing a New Trial
Market
$4.02

Salandit
Facing a New Trial
No recent price